We only have this paper's title and publication details.
Read it at the sourceRandomized double-blind trial reveals reduced lipid concentrations and hepatic markers in individuals with suboptimal cholesterol levels, suggesting therapeutic value for cardiovascular risk.
No takes yet. Share an insight, caveat, or question.
Fogacci et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: